Business Context and Reporting Period
This Form 8-K Current Report was filed by Harrow, Inc. (formerly Harrow Health, Inc.) on September 29, 2023. The filing documents a corporate name change effective as of the report date, approved by the Board of Directors without requiring stockholder approval under Delaware General Corporation Law.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance changes rather than a periodic financial statement.
Material Changes
- Corporate Name: Changed from "Harrow Health, Inc." to "Harrow, Inc."
- Governance Documents: The Company amended and restated its Certificate of Incorporation and Bylaws solely to reflect the name change.
- Stockholder Rights: The name change does not affect the rights of the Company's stockholders.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly procedural regarding the name change and the filing of associated exhibits.
Investor Verification Checklist
- Verify the updated ticker symbol and trading status for "Harrow, Inc." on The Nasdaq Stock Market LLC.
- Confirm the updated legal name in investor records and trading platforms.
- Review the Amended and Restated Certificate of Incorporation (Exhibit 3.1) and Bylaws (Exhibit 3.2) for any clauses beyond the name change.
- Check the press release (Exhibit 99.1) for strategic context regarding the rebranding.